Moomoo AI 已提取核心訊息
Cardio Diagnostics Holdings, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a correspondence dated January 30, 2024. The company has sought for the Registration Statement, with File No. 333-276725, to be declared effective on February 1, 2024, at 11:00 a.m. Eastern Time or as soon thereafter as practicable. This request was made under Rule 461 of the Securities Act of 1933, as amended. Cardio Diagnostics Holdings has indicated that once the Registration Statement is declared effective, the SEC should orally confirm the event with the company's counsel, Shartsis Friese LLP, specifically Rupert Russell. Any questions or comments from the SEC regarding this acceleration request are to be directed to Mr. Russell.
Cardio Diagnostics Holdings, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a correspondence dated January 30, 2024. The company has sought for the Registration Statement, with File No. 333-276725, to be declared effective on February 1, 2024, at 11:00 a.m. Eastern Time or as soon thereafter as practicable. This request was made under Rule 461 of the Securities Act of 1933, as amended. Cardio Diagnostics Holdings has indicated that once the Registration Statement is declared effective, the SEC should orally confirm the event with the company's counsel, Shartsis Friese LLP, specifically Rupert Russell. Any questions or comments from the SEC regarding this acceleration request are to be directed to Mr. Russell.
根據2024年1月30日的信函，Cardio Diagnostics Holdings, Inc.已正式要求美國證券交易委員會（SEC）加快其S-3表格註冊聲明的生效日期。該公司已尋求於美國東部時間2024年2月1日上午11點或此後在切實可行的情況下儘快宣佈註冊聲明（文件編號爲333-276725）生效。該請求是根據經修訂的1933年《證券法》第461條提出的。Cardio Diagnostics Holdings表示，一旦宣佈註冊聲明生效，美國證券交易委員會應與該公司的法律顧問Shartsis Friese LLP，特別是魯珀特·羅素口頭確認這一事件。美國證券交易委員會對該加速請求的任何問題或評論均應直接聯繫羅素先生。
根據2024年1月30日的信函，Cardio Diagnostics Holdings, Inc.已正式要求美國證券交易委員會（SEC）加快其S-3表格註冊聲明的生效日期。該公司已尋求於美國東部時間2024年2月1日上午11點或此後在切實可行的情況下儘快宣佈註冊聲明（文件編號爲333-276725）生效。該請求是根據經修訂的1933年《證券法》第461條提出的。Cardio Diagnostics Holdings表示，一旦宣佈註冊聲明生效，美國證券交易委員會應與該公司的法律顧問Shartsis Friese LLP，特別是魯珀特·羅素口頭確認這一事件。美國證券交易委員會對該加速請求的任何問題或評論均應直接聯繫羅素先生。
有用
沒用
該公告為獨立文件：